IGC Pharma, Inc. has added Pablo Arbelaez, Ph.D., an expert in artificial intelligence, to support the development of their lead therapeutic candidate for Alzheimer’s…
IGC Pharma, Inc. has added Pablo Arbelaez, Ph.D., an expert in artificial intelligence, to support the development of their lead therapeutic candidate for Alzheimer’s…
Login below or Register Now.
Already registered? Login.